Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Douglas K. Logan
Observed name:
Douglas Logan
Institutions:
Brigham and Women's Hospital,
Harvard University,
Cincinnati VA Medical Center
Observed institutions:
Brigham and Women's Hospital,
Medpace (United States),
Harvard University,
Regeneron (United States),
University of Tennessee Medical Center,
Cincinnati VA Medical Center,
Catabasis Pharmaceuticals (United States)
show all 7
OpenAlex ID:
A5039000495
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
2012
·
Evan A. Stein
, Scott Mellis
, et al.
·
New England Journal of Medicine
·
716
PDF
Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
2017
·
Deepak L. Bhatt
, Tilo Grosser
, et al.
·
Journal of the American College of Cardiology
·
162
PDF
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel
2013
·
Paul A. Gurbel
, Kevin P. Bliden
, et al.
·
Journal of the American College of Cardiology
·
155
Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease
2012
·
Matthew J. Price
, James S. Walder
, et al.
·
Journal of the American College of Cardiology
·
130
Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
2014
·
Robert R. Henry
, Julio Rosenstock
, et al.
·
Journal of Diabetes and its Complications
·
87
PDF
Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD‐6972 in healthy subjects and subjects with type 2 diabetes mellitus
2016
·
Eric G. Vajda
, Douglas Logan
, et al.
·
Diabetes Obesity and Metabolism
·
48
PDF
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
2013
·
Robert R. Henry
, Julio Rosenstock
, et al.
·
Diabetes Care
·
43
A Randomized, Open-Label, Multicenter, 4-Week Study to Evaluate the Tolerability and Pharmacokinetics of ITCA 650 in Patients With Type 2 Diabetes☆☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
2013
·
Robert R. Henry
, Douglas Logan
, et al.
·
Clinical Therapeutics
·
29
PDF
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials
2025
·
Neal Bhatia
, James Del Rosso
, et al.
·
JAMA Dermatology
·
16
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
2012
·
Evan A. Stein
, Scott Mellis
, et al.
·
Obstetrical & Gynecological Survey
·
15
Abstract 16265: Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 With a Monoclonal Antibody REGN727/SAR236553, Effectively Reduces Low-Density-Lipoprotein Cholesterol, as Mono or Add-on Therapy in Heterozygous Familial and Non Familial Hypercholesterolemia
2011
·
Gary D. Swergold
, W. Smith
, et al.
·
Circulation
·
7
Phase 1 Single and Multiple Ascending Dose Study of Cat-2003, a Novel Activator of Lipoprotein Lipase, Demonstrates Reductions in Postprandial Triglycerides
2014
·
Joanne Donovan
, Richard Dunbar
, et al.
·
Journal of the American College of Cardiology
·
6
PDF
Recovery of Platelet Function Following Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-treated Subjects With Stable Coronary Disease: the Recovery Trial
2011
·
Matthew J. Price
, Douglas K. Logan
, et al.
·
Journal of the American College of Cardiology
·
5
PDF
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes. Diabetes Care 2013;36:2559–2565
2013
·
Robert R. Henry
, Julio Rosenstock
, et al.
·
Diabetes Care
·
3
TCT-54 The Influence of Smoking Status On The Pharmacodynamics of Prasugrel and Clopidogrel:The PARADOX Study
2012
·
Paul Gurbel
, Kevin Bliden
, et al.
·
Journal of the American College of Cardiology
·
3
PDF
Reply
2017
·
Deepak L. Bhatt
, Tilo Grosser
, et al.
·
Journal of the American College of Cardiology
·
1
PDF
Phase 1 Single and Multiple Ascending Dose Study of CAT-2003, a Novel Activator of Lipoprotein Lipase, Decreases Postprandial Triglycerides†
2014
·
Joanne M. Donovan
, Richard Dunbar
, et al.
·
Journal of clinical lipidology
·
1
Show more works
View as search
Works count:
17
Citation count:
1,427
H-index:
10
I10-index:
10
Year
Topic
Type